Main Line biotech firm completes reverse merger, raises $78.9 million
Dec 16, 2024
The focus of the combined company is developing new treatment for rare genetic skin diseases.
https://www.bizjournals.com/philadelphia/news/2024/12/16/palvella-wayne-reverse-merger-pieris-789m-skin.html?ana=RSS&s=article_search
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service